474334-89-9

Basic information

• Product Name: 1-(3-CARBOMETHOXYPHENYL)-4-METHYLPIPERA&
• Synonyms: Methyl 3-(4-Methyl-1-piperazinyl)benzoate, 97%;Methyl 3-(4-Methylpiperazin-1-yl)benzoate
• CAS NO: 474334-89-9
• Molecular Formula: C₁₃H₁₈N₂O₂
• Molecular Weight: 234.297
• Product Categories: API intermediates;piperazines
• Mol File: 474334-89-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 169-172 °C/0.9 mmHg(lit.)
• Flash Point: 110 °C
• Appearance: Colorless to dark yellow/Liquid
• Density: 1.119 g/mL at 25 °C(lit.)
• Vapor Pressure: 1.94E-05mmHg at 25°C
• Refractive Index: n20/D 1.563(lit.)
• PKA: 7.67±0.42(Predicted)
• CAS DataBase Reference: 1-(3-CARBOMETHOXYPHENYL)-4-METHYLPIPERA&(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-CARBOMETHOXYPHENYL)-4-METHYLPIPERA&(474334-89-9)
• EPA Substance Registry System: 1-(3-CARBOMETHOXYPHENYL)-4-METHYLPIPERA&(474334-89-9)

Safety Data

• Hazard Codes: Xi
• Safety Statements: 36/37
• WGK Germany: 3
• Hazardous Substances Data: 474334-89-9(Hazardous Substances Data)

Usage

General Description

1-(3-carbomethoxyphenyl)-4-methylpiperazine, also known as mCPP, is a psychoactive drug with stimulant and hallucinogenic effects. It is chemically classified as a piperazine derivative and is commonly used in scientific research to study serotonergic pathways in the brain. mCPP has been found to act as a serotonin receptor agonist, particularly at the 5-HT2C receptor, and has also been investigated for its potential therapeutic effects in conditions such as depression, anxiety, and obesity. However, mCPP is not approved for medical use and is considered a controlled substance in many countries due to its potential for abuse and adverse effects on mental health.

InChI:InChI=1/C13H18N2O2/c1-14-6-8-15(9-7-14)12-5-3-4-11(10-12)13(16)17-2/h3-5,10H,6-9H2,1-2H3

Upstream product

• 109-01-3 1-methyl-piperazine 
• 618-91-7 methyl 3-iodo-benzoate 

Downstream Products

• 215309-01-6 3-(4-methyl-1-piperazinyl)benzoic acid 
• 1269515-44-7 3-(3-(4-methylpiperazin-1-yl)phenyl)-3-oxopropanenitrile 
• 123987-13-3 (3-(4-methylpiperazin-1-yl)phenyl)methanol 
• 1055927-86-0 3-(4-methyl-1-piperazinyl) benzoyl chloride 
• 1055925-65-9 N'-(2-cyano-9-methyl-9H-purin-6-yI)-N'-cyclopentyl-3-(4-methyl-1-piperazinyl)benzohydrazide 
• 1055925-74-0 N'-(2-cyano-9-methyl-9H-purin-6-yI)-N'-cyclohexyl-3-(4-methyl-1-piperazinyl)benzohydrazide 
• 1055925-88-6 N'-{2-cyano-9-[2-(dimethylamino)ethyl]-9H-purin-6-yl}-N'-cyclopentyl-3-(4-methyl-1-piperazinyl)benzohydrazide 
• 1055925-77-3 N'-{2-cyano-9-[3-(dimethylamino)propyl]-9H-purin-6-yI}-N'-cyclopentyl-3-(4-methyl-1-piperazinyl)benzohydrazide 
• 1055925-66-0 N'-(2-cyano-9-methyl-9H-purin-6-yI)-N'-cyclopentyl-3-(4-methyl-1-piperazinyl)benzohydrazide trifluoroacetate 
• 1055925-75-1 N'-(2-cyano-9-methyl-9H-purin-6-yI)-N'-cyclohexyl-3-(4-methyl-1-piperazinyl)benzohydrazide trifluoroacetate 
• 1055925-78-4 N'-{2-cyano-9-[3-(dimethylamino)propyl]-9H-purin-6-yI}-N'-cyclopentyl-3-(4-methyl-1-piperazinyl)benzohydrazide trifluoroacetate 

Relevant articles and documents

OXABOROLE ESTERS AND USES THEREOF

The present invention provides oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as Chagas Disease and African Animal Trypanosomosis.